Bellicum Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Dave Maggio
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.3yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
CEO
Dave Maggio (63 yo)
less than a year
Tenure
Mr. David M. Maggio, also known as Dave, serves as Chief Executive Officer of Bellicum Pharmaceuticals, Inc. since February 2, 2024. Mr. Maggio has broad domestic and global experience in executing financi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | no data | no data | |
| Senior Vice President of Technical Operations & Quality | 2.3yrs | no data | no data | |
| Chief Scientific Officer | 3.8yrs | US$791.68k | no data |
2.3yrs
Average Tenure
63yo
Average Age
Experienced Management: BPXA's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | less than a year | US$1.39m | 0.11% € 826.3 | |
| Member of Scientific & Clinical Advisory Board | 5.1yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | 5.1yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | 5.1yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | 5.1yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | 5.1yrs | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data |
5.1yrs
Average Tenure
Experienced Board: BPXA's board of directors are considered experienced (5.1 years average tenure).